| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.093 | 0.09 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.09 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.1 |